Avoro Capital Advisors LLC Diversified Active

Location: New York, NY

CIK: 0001633313 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Feb 14, 2017

Total Value: $495M (99.7% shares, 0.3% debt)

Holdings (43)

ACAD ACADIA PHARMACEUTICALS INC 8.7%

Value $42.87M Shares 1,486,460 Est. Cost $30.33 Unrealized -12.8%

— IMMUNOMEDICS INC 6.9%

Value $34M Shares 9,263,340 Est. Cost $2.62 Unrealized —

BMRN BIOMARIN PHARMACEUTICAL INC 6.7%

Value $33.14M Shares 400,000 Est. Cost $82.68 Unrealized +4.0%

— LION BIOTECHNOLOGIES INC 6.3%

Value $31.42M Shares 4,520,643 Est. Cost $9.92 Unrealized —

— TESARO INC 6.3%

Value $31.16M Shares 231,700 Est. Cost $72.37 Unrealized —

SRPT SAREPTA THERAPEUTICS INC 5.6%

Value $27.71M Shares 1,010,300 Est. Cost $23.48 Unrealized +71.1%

— NEURODERM LTD 4.7%

Value $23.45M Shares 1,056,303 Est. Cost $19.87 Unrealized —

— DERMIRA INC 4.7%

Value $23.22M Shares 765,709 Est. Cost $28.44 Unrealized —

— AERIE PHARMACEUTICALS INC 4.7%

Value $23.09M Shares 610,000 Est. Cost $37.76 Unrealized —

NBIX NEUROCRINE BIOSCIENCES INC 4.2%

Value $20.94M Shares 541,000 Est. Cost $43.90 Unrealized +3.1%

— ALEXION PHARMACEUTICALS INC 4.2%

Value $20.8M Shares 170,000 Est. Cost $122.35 Unrealized —

FOLD AMICUS THERAPEUTICS INC 4.0%

Value $19.97M Shares 4,017,577 Est. Cost $7.74 Unrealized -10.6%

BMY BRISTOL MYERS SQUIBB CO. 3.4%

Value $16.66M Shares 285,000 Est. Cost $48.26 Unrealized -18.1%

— SEATTLE GENETICS INC 3.2%

Value $15.6M Shares 295,533 Est. Cost $53.36 Unrealized —

— AGENUS INC 3.1%

Value $15.45M Shares 3,750,430 Est. Cost $4.72 Unrealized —

— GLOBAL BLOOD THERAPEUTICS INC 2.9%

Value $14.39M Shares 995,838 Est. Cost $16.18 Unrealized —

ASND ASCENDIS PHARMA 2.2%

Value $11.04M Shares 545,203 Est. Cost $20.23 Unrealized —

— TELIGENT INC 2.2%

Value $11M Shares 1,663,619 Est. Cost $8.21 Unrealized —

BCRX BIOCRYST PHARMACEUTICALS INC 2.1%

Value $10.33M Shares 1,631,502 Est. Cost $4.18 Unrealized +24.4%

AKBA AKEBIA THERAPEUTICS INC 1.7%

Value $8.656M Shares 831,515 Est. Cost $8.65 Unrealized -0.5%

— MIRATI THERAPEUTICS INC 1.4%

Value $7.164M Shares 1,508,201 Est. Cost $26.09 Unrealized —

SRNE SORRENTO THERAPEUTICS INC 1.4%

Value $7.135M Shares 1,456,056 Est. Cost $8.13 Unrealized -26.1%

VCYT VERACYTE INC 1.4%

Value $7.02M Shares 906,999 Est. Cost $8.92 Unrealized -16.2%

VNDA VANDA PHARMACEUTICALS INC 1.2%

Value $6.084M Shares 381,466 Est. Cost $11.57 Unrealized +39.0%

— ALIMERA SCIENCES INC 0.9%

Value $4.357M Shares 4,034,488 Est. Cost $1.44 Unrealized —

— CASCADIAN THERAPEUTICS INC 0.8%

Value $3.971M Shares 921,248 Est. Cost $4.31 Unrealized —

XNCR XENCOR INC 0.7%

Value $3.29M Shares 125,000 Est. Cost $24.05 Unrealized 0.0%

— ASSEMBLY BIOSCIENCES INC 0.7%

Value $3.284M Shares 270,289 Est. Cost $5.59 Unrealized —

— FORTRESS BIOTECH INC 0.7%

Value $3.241M Shares 1,200,342 Est. Cost $3.13 Unrealized —

CRVS CORVUS PHARMACEUTICALS INC 0.6%

Value $3.098M Shares 216,619 Est. Cost $14.40 Unrealized +5.6%

— ONCOBIOLOGICS INC 0.4%

Value $2.057M Shares 683,531 Est. Cost $3.27 Unrealized —

CLLS CELLECTIS - ADR 0.3%

Value $1.646M Shares 97,096 Est. Cost $24.12 Unrealized —

— PERNIX THERAPEUTICS HOLDINGS INC 0.3%

Value $1.479M Shares 6,000,000 Est. Cost $0.21 Unrealized —

— ARRAY BIOPHARMA INC 0.3%

Value $1.406M Shares 160,000 Est. Cost $8.79 Unrealized —

— TRILLIUM THERAPEUTICS INC 0.3%

Value $1.285M Shares 227,399 Est. Cost $15.46 Unrealized —

CPRX CATALYST PHARMACEUTICALS INC 0.2%

Value $1.198M Shares 1,141,149 Est. Cost $1.14 Unrealized 0.0%

— BIODELIVERY SCIENCES INTL INC 0.2%

Value $1.127M Shares 644,176 Est. Cost $1.75 Unrealized —

SRPT SAREPTA THERAPEUTICS INC 0.1%

Value $615K Shares 150,000 Est. Cost $23.48 Unrealized +71.1%

ACAD ACADIA PHARMACEUTICALS INC 0.1%

Value $413K Shares 200,000 Est. Cost $30.33 Unrealized -12.8%

— ONCOBIOLOGICS INC - WARRANT B 0.0%

Value $184K Shares 233,333 Est. Cost $0.45 Unrealized —

— ONCOBIOLOGICS INC - WARRANT A 0.0%

Value $44,000 Shares 233,333 Est. Cost $0.46 Unrealized —

— AGENUS INC 0.0%

Value $25,000 Shares 1,000,000 Est. Cost $4.72 Unrealized —

— IMMUNOMEDICS INC 0.0%

Value $23,000 Shares 300,800 Est. Cost $2.62 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACAD	ACADIA PHARMACEUTICALS INC	1,486,460	$42.87M	8.7%	$30.33	-12.8%	Common	004225108
—	IMMUNOMEDICS INC	9,263,340	$34M	6.9%	$2.62	—	Common	452907108
BMRN	BIOMARIN PHARMACEUTICAL INC	400,000	$33.14M	6.7%	$82.68	+4.0%	Common	09061G101
—	LION BIOTECHNOLOGIES INC	4,520,643	$31.42M	6.3%	$9.92	—	Common	53619R102
—	TESARO INC	231,700	$31.16M	6.3%	$72.37	—	Common	881569107
SRPT	SAREPTA THERAPEUTICS INC	1,010,300	$27.71M	5.6%	$23.48	+71.1%	Common	803607100
—	NEURODERM LTD	1,056,303	$23.45M	4.7%	$19.87	—	Common	M74231107
—	DERMIRA INC	765,709	$23.22M	4.7%	$28.44	—	Common	24983L104
—	AERIE PHARMACEUTICALS INC	610,000	$23.09M	4.7%	$37.76	—	Common	00771V108
NBIX	NEUROCRINE BIOSCIENCES INC	541,000	$20.94M	4.2%	$43.90	+3.1%	Common	64125C109
—	ALEXION PHARMACEUTICALS INC	170,000	$20.8M	4.2%	$122.35	—	Common	015351109
FOLD	AMICUS THERAPEUTICS INC	4,017,577	$19.97M	4.0%	$7.74	-10.6%	Common	03152W109
BMY	BRISTOL MYERS SQUIBB CO.	285,000	$16.66M	3.4%	$48.26	-18.1%	Common	110122108
—	SEATTLE GENETICS INC	295,533	$15.6M	3.2%	$53.36	—	Common	812578102
—	AGENUS INC	3,750,430	$15.45M	3.1%	$4.72	—	Common	00847G705
—	GLOBAL BLOOD THERAPEUTICS INC	995,838	$14.39M	2.9%	$16.18	—	Common	37890U108
ASND	ASCENDIS PHARMA	545,203	$11.04M	2.2%	$20.23	—	Sponsored ADR	04351P101
—	TELIGENT INC	1,663,619	$11M	2.2%	$8.21	—	Common	87960W104
BCRX	BIOCRYST PHARMACEUTICALS INC	1,631,502	$10.33M	2.1%	$4.18	+24.4%	Common	09058V103
AKBA	AKEBIA THERAPEUTICS INC	831,515	$8.656M	1.7%	$8.65	-0.5%	Common	00972D105
—	MIRATI THERAPEUTICS INC	1,508,201	$7.164M	1.4%	$26.09	—	Common	60468T105
SRNE	SORRENTO THERAPEUTICS INC	1,456,056	$7.135M	1.4%	$8.13	-26.1%	Common	83587F202
VCYT	VERACYTE INC	906,999	$7.02M	1.4%	$8.92	-16.2%	Common	92337F107
VNDA	VANDA PHARMACEUTICALS INC	381,466	$6.084M	1.2%	$11.57	+39.0%	Common	921659108
—	ALIMERA SCIENCES INC	4,034,488	$4.357M	0.9%	$1.44	—	Common	016259103
—	CASCADIAN THERAPEUTICS INC	921,248	$3.971M	0.8%	$4.31	—	Common	14740B606
XNCR	XENCOR INC	125,000	$3.29M	0.7%	$24.05	0.0%	Common	98401F105
—	ASSEMBLY BIOSCIENCES INC	270,289	$3.284M	0.7%	$5.59	—	Common	045396108
—	FORTRESS BIOTECH INC	1,200,342	$3.241M	0.7%	$3.13	—	Common	34960Q109
CRVS	CORVUS PHARMACEUTICALS INC	216,619	$3.098M	0.6%	$14.40	+5.6%	Common	221015100
—	ONCOBIOLOGICS INC	683,531	$2.057M	0.4%	$3.27	—	Common	68235M105
CLLS	CELLECTIS - ADR	97,096	$1.646M	0.3%	$24.12	—	Sponsored ADR	15117K103
—	PERNIX THERAPEUTICS HOLDINGS INC	6,000,000	$1.479M	0.3%	$0.21	—	Convertible Debt	71426VAK4
—	ARRAY BIOPHARMA INC	160,000	$1.406M	0.3%	$8.79	—	Common	04269X105
—	TRILLIUM THERAPEUTICS INC	227,399	$1.285M	0.3%	$15.46	—	Common	89620X506
CPRX	CATALYST PHARMACEUTICALS INC	1,141,149	$1.198M	0.2%	$1.14	0.0%	Common	14888U101
—	BIODELIVERY SCIENCES INTL INC	644,176	$1.127M	0.2%	$1.75	—	Common	09060J106
SRPT	SAREPTA THERAPEUTICS INC	150,000	$615K	0.1%	$23.48	+71.1%	Put	803607100
ACAD	ACADIA PHARMACEUTICALS INC	200,000	$413K	0.1%	$30.33	-12.8%	Call	004225108
—	ONCOBIOLOGICS INC - WARRANT B	233,333	$184K	0.0%	$0.45	—	Warrant	68235M121
—	ONCOBIOLOGICS INC - WARRANT A	233,333	$44,000	0.0%	$0.46	—	Warrant	68235M113
—	AGENUS INC	1,000,000	$25,000	0.0%	$4.72	—	Call	00847G705
—	IMMUNOMEDICS INC	300,800	$23,000	0.0%	$2.62	—	Call	452907108